John Mykytiuk

Title: Innovations of John Mykytiuk

Introduction

John Mykytiuk is a notable inventor based in Sunderland, GB. He has made significant contributions to the field of therapeutic agents, particularly in the treatment and prevention of proliferative diseases such as cancer. With a total of two patents to his name, Mykytiuk's work showcases his dedication to advancing medical science.

Latest Patents

Mykytiuk's latest patents include the development of Ditosylate salts of N2-(2-ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine, along with crystalline forms thereof. These patents also detail processes for the preparation of these new salt forms and their use as therapeutic agents. Additionally, he has patented Diphosphate salts of the same compound, emphasizing their potential in combating proliferative diseases.

Career Highlights

Throughout his career, Mykytiuk has worked with various companies, including Crt Pioneer Fund LP and Pulmocide Limited. His experience in these organizations has contributed to his expertise in the pharmaceutical field and has allowed him to focus on innovative solutions for serious health issues.

Collaborations

Mykytiuk has collaborated with notable professionals in his field, including Julian S Northen and Gillian Moore. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

John Mykytiuk's contributions to the field of therapeutic agents highlight his commitment to innovation and improving health outcomes. His patents reflect a significant advancement in the treatment of proliferative diseases, showcasing the importance of continued research and development in medicine.